Target intelligence / Profile preview

Kinase signaling and survival pathways

Molecular classification
Enzyme, Signal transduction protein
01

Overview

Kinase signaling and survival pathways are complex, interconnected networks of enzymes that relay extracellular signals to the nucleus to regulate fundamental cellular processes. These pathways, most notably the PI3K/AKT/mTOR and MAPK/ERK cascades, play a critical role in promoting cell growth, metabolism, and resistance to programmed cell death (StatPearls, 2023). In many forms of cancer, these pathways are pathologically activated by mutations, amplifications, or overexpressed receptors, leading to uncontrolled proliferation and survival (Nature Reviews Cancer, 2021). Pharmacological targeting of these pathways involves a wide array of small-molecule inhibitors and monoclonal antibodies designed to disrupt specific nodes in the signaling chain. While these therapies have revolutionized treatment for various malignancies, their efficacy is often limited by the emergence of resistance through bypass signaling or secondary mutations (PubMed, 2022). Furthermore, because these pathways are essential for normal physiological functions, their inhibition can result in significant side effects, requiring careful patient monitoring and dose management.

Other names
Cell survival signalingKinase-mediated survival pathwaysIntracellular survival cascades
02

Mechanism of action

Inhibition of specific protein kinases (tyrosine or serine/threonine) to block downstream signaling that promotes cell growth and prevents apoptosis.

03

Biological functions

Signal transductionCell survivalCell proliferationApoptosisMetabolism
04

Disease associations

CancerInflammationNeurodegenerative diseaseAutoimmune disease
05

Safety considerations

Off-target kinase inhibitionActivation of compensatory feedback loopsSystemic toxicity (e.g., hepatotoxicity, cardiotoxicity)Acquired drug resistance
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

p-AKT levelsp-ERK levelsBRAF V600E mutationPIK3CA mutationPTEN loss

Beyond the preview

Go deeper on Kinase signaling and survival pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinase signaling and survival pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call